CVE-2025-31281
Apple iPadOS vulnerability
- Published29 Jul 2025
Description
An input validation issue was addressed with improved memory handling. This issue is fixed in iOS 18.6 and iPadOS 18.6, macOS Sequoia 15.6, tvOS 18.6, visionOS 2.6. Processing a maliciously crafted file may lead to unexpected app termination.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:HAffected products
Remediation
References
- http://seclists.org/fulldisclosure/2025/Jul/30
- http://seclists.org/fulldisclosure/2025/Jul/32
- http://seclists.org/fulldisclosure/2025/Jul/36
- http://seclists.org/fulldisclosure/2025/Jul/37
- https://support.apple.com/en-us/124147
- https://support.apple.com/en-us/124149
- https://support.apple.com/en-us/124153
- https://support.apple.com/en-us/124154
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2025-31281 being actively exploited?
CVE-2025-31281 is not in the CISA KEV catalog. Its EPSS exploit probability is 1.15%.
How severe is CVE-2025-31281?
CVE-2025-31281 has a CVSS 3.1 base score of 9.1, rated critical. EPSS estimates a 1.15% probability of exploitation.
Which products are affected by CVE-2025-31281?
Affected products include Apple iPadOS, Apple iPhone OS, Apple macOS, Apple Tvos, Apple Visionos.
How do I fix CVE-2025-31281?
Upgrade affected software to a fixed version, for example Apple iPadOS 18.6, Apple iPhone OS 18.6, Apple macOS 15.6 or later, then confirm no affected versions remain in your inventory.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2025-31281 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.